Aurora Crespo De la Jara
- Hospital Quirónsalud Torrevieja
- Nuclear Medicine
Born in Madrid in 1971, she completed her medical studies at the Complutense University of Madrid, in 1995. She specialized in Nuclear Medicine at the University Clinic of Navarra in 2001, and an associate professor at the Faculty of Medicine of the University of Navarra during that period. . Since 2001 he works as a nuclear medicine at the Oncology Platform of the Hospital Quirónsalud Torrevieja, Alicante, being responsible for the Diagnostic and Therapeutic Units of Nuclear Medicine. She is secretary of the Executive Committee of TEDECA and member of the Pharmacy Commission and the Ethical Committee of this hospital.
Areas of expertise. In PET-CT, forming in the University Clinic of Navarra (one of the two pioneering centers in Spain in this discipline), with an accumulated experience of more than 10 years. In the performance of radiometabolic treatments in different indications: thyroid cancer, neuroendocrine tumors, bone metastases and liver tumors (being the first Spanish center to perform treatments with 131I-Lipiodol). In limb perfusion monitoring with TNF, actively participating in the development and implementation of this therapeutic modality and in obtaining the pertinent authorizations in two of the only three centers authorized for this in Spain. In detection of sentinel lymph node with experience in breast, melanoma, gynecological and head and neck tumors.
Specialities that it attends:
Information and medical appointment
(+34) 966 921 313 / (+34) 966 925 761
- Head of the Diagnostic and Therapeutic Unit of Nuclear Medicine-Oncology Platform since 2001.
- Bachelor of Medicine and Surgery from the Complutense University of Madrid.
- Specialist in Nuclear Medicine by the University Clinic of Navarra in 2001.
- Recognition of research proficiency with an outstanding qualification from the University of Navarra in 2003.
- Expert in Radiopharmacy by the Spanish Society of Nuclear Medicine.
- Supervisor of Radioactive Installations.
- Active member of the Spanish and Valencian Society of Nuclear Medicine, of the European Association of Nuclear Medicine and of the American Society of Nuclear Medicine.
COLLABORATION IN CONGRESSES AND SCIENTIFIC PUBLICATIONS
-Crespo-Jara A, y cols. Treatment of Unresectable or Relapsed Hepatocellular Carcinoma (HCC) with Iodine-131-labeled Lipiodol +/- Pegylated Liposomal Doxorubicin (PLD) Oral communication in the European Association of Nuclear Medicine, Copenhaguen 2007.
-Crespo A, Sureda M, Vazquez B, Rebollo J, Calvo E, Garcia F, Brugarolas A. Bone-targeted therapy in advanced androgen-independent prostate carcinoma: a feasibility study. Meeting: 2005 ASCO Annual Meeting. Abstract No: 4793
-Crespo A, García MJ, Giménez M, Calvo R, Peñuelas I, Gámez C, Richter JA. Skeletal metastases in lung cancer. Accuracy of 18-FDG-PET in correlaction with bone scintigraphy. 46 th annual Meeting of Society of Nuclear Medicine. Los Angeles, Junio 1999. J.Nucl.Med. Vol 40, Mayo 1999.
-Crespo-Jara A, Giménez M, Villar L.M, Velloso M.J, Peñuelas Y, Boán J, Salvador J, Gomez-Peralta F, Richter J.A. Evaluation of adrenal masses in lung cancer using 18FDG-PET.
47th annual Meeting of Society of Nuclear Medicine, St.Louis, Junio 2000.
J.Nucl.Med., May 2000-Supplement, vol 41, nº5: 293P
-Calvo R, Martí J, Richter JA, Peñuelas I, Crespo A, Villar L, García Velloso MJ. TITULO: "3D Clinical PET in lung cancer: validation and practical strategies". J Nucl. Med, 2000 ; 41: 439-